Global Continuous Renal Replacement Therapy Market– Industry Trends and Forecast to 2025

  • Healthcare IT
  • Upcoming Reports
  • Jul 2018
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Continuous Renal Replacement Therapy Market, By Product Type (Systems, Consumables {Filters, Tubing sets, Disposables}, Dialysates, Replacement Fluids), By Modality (Continuous Veno-Venous Hemofiltration (CVVH), Continuous Veno-Venous Hemodifiltration (CVVHDF), Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemodialysis (CVVHD), Therapeutic Plasma Exchange (TPE)), End User (Hospitals, Homecare Settings, Clinic), By Geography (North America, Europe, Middle East and Africa, South America)– Industry Trends and Forecast to 2025

Market Analysis: Global Continuous Renal Replacement Therapy Market

The Global Continuous Renal Replacement Therapy Market is expected to reach USD 1.87 billion by 2025, from USD 1.09 billion in 2017 growing at a CAGR of 7% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016 , the base year of calculation is 2016 and the forecast period is 2018 to 2025.

Market Definition: Global Continuous Renal Replacement Therapy Market

Acute renal failure is reversible impairment in kidney function, depending upon cause and extent of being untreated. The continuous replacement renal therapy is innovative therapy for haemodialysis patients who cannot tolerate conventional Intermittent Haemodialysis (IHD) due to hemodynamic instability. There is increase in prevalence rate in kidney failure across the globe. For instance, according to national kidney foundation, over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive. Continuous renal replacement therapy has been preferred over conventional methods of dialysis. According to recent US Renal Data System estimates, more than 900,000 patients worldwide have end stage renal disease (ESRD) and are on renal replacement therapy. There have been tremendous technological advancements in the field of renal replacement therapy in the last decade. In September 2017, Baxter International Inc. (U.S.), a global leader in acute care therapies, announced that commercial launch of a new indication for the company’s oXiris set, which can now be used to help remove excessive levels of cytokines, endotoxin and other inflammatory mediators from a patient’s blood. According to kidney research UK over a ten-year period from 2005 to 2015, the number of people dying from chronic kidney disease across the world rose by 31.7%. According to world health organization, the number receiving renal replacement therapy (RRT) is estimated to be more than 1.4 million with incidence growing by approximately 8.0% annually.

Major Market Drivers and Restraints:

  • Increase prevalence rate of acute kidney disorders
  • New product launch and technological advancements
  • Rising prevalence of diabetes and hypertension
  • Stringent regulatory guidelines
  • High cost of procedure.
  • Highly advanced multi-functional continuous renal replacement therapy and changing nature of healthcare industry may drive up revenue growth of market

Market Segmentation: Global Continuous Renal Replacement Therapy Market

  • The global continuous renal replacement therapy market is segmented based on product type, modality, end user and geographical segments.
  • Based on product type the global continuous renal replacement therapy market is segmented into systems, dialysates and replacement fluids and consumables. The consumable segment is further sub-segmented on the basis of product type into filters, tubing sets, disposables.
  • The global continuous replacement therapy market segment is further segmented into modality. By modality it is further segmented into (Continuous Veno-Venous Hemofiltration (CVVH), Continous Veno-Venous Hemodifiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF), and Therapeutic Plasma Exchange (TPE)
  • On the basis of end users, the market is segmented into hospitals, homecare settings and clinics.
  • Based on geography, the market report covers data points for 24 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Key Developments in the Market: Global Continuous Renal Replacement Therapy Market

  • In November, 2013 B. Braun Melsungen AG (Germany) and DaVita Inc. (U.S.) entered into an agreement for the supply of dialysis products for renal therapy.
  • Cara Therapeutics, Inc. (U.S.) licensed worldwide rights, except in the U.S., Japan, and South Korea, to commercialize Korsuva (CR845/difelikefalin) injection for the treatment of chronic kidney disease-associated pruritus (CKD-aP) in dialysis patients to Vifor Pharma Management Ltd.( Switzerland).

Competitive Analysis: Global Continuous Renal Replacement Therapy Market

The global continuous renal replacement therapy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes global continuous renal replacement therapy market for global, Europe, North America, Asia Pacific and Latin America.

Major Market Competitors/Players: Global Continuous Renal Replacement Therapy Market

Some of the major players operating in the global continuous renal replacement therapy market are B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, and Asahi Kasei Medical Co. Ltd., Baxter International Inc., Bellco S.R.L, Covidien Ltd., Diaverum, Gambro AB, Infomed SA, Medica S.P.A, Medical Components, Inc., Medical Components, Inc., Medites Pharma spol. S R.o., Nikkiso Co., Ltd, Nxstage Medical, Inc., Toray Medical Company Limited, Terumo BCT etc.

Research Methodology: Global Continuous Renal Replacement Therapy Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst call or can drop down your inquiry.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of global continuous renal replacement therapy market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players 

Customization of the Report

  • The report includes the complete segmentation displayed above across all above mentioned countries
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00